View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AP52 | Publication ID: Spring 2009 |
Title: Medicare Advantage and Prescription Drug Programs: MIPPA-Related Marketing Revisions (CMS-4138-F) | |
Abstract: This final rule revises the regulations governing the Medicare Advantage program (part C), and the prescription drug benefit program (part D). | |
Agency: Department of Health and Human Services(HHS) | Priority: Other Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Long-Term Actions |
Major: No | Unfunded Mandates: No |
CFR Citation: 42 CFR 417 42 CFR 422 and 423 | |
Legal Authority: 42 USC 1395w-28(f) |
Legal Deadline:
|
||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Federal |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Jerry Mulcahy Division Director of Policy Anaylsis and Planning Group Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Drug and Healthplan Choice, Mailstop C4-23-07, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-1142 Email: jerry.mulcahy@cms.hhs.gov |